Richard Peters's Net Worth
$177 Thousand
Who is Richard Peters?
Richard Peters does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KINETA, INC./DE, MERRIMACK PHARMACEUTICALS INC, and Aprea Therapeutics, Inc..
SEC CIK
Richard Peters's CIK is 0001697628
Past Insider Trading and Trends
2021 was Richard Peters's most active year for acquiring shares with 6 total transactions. Richard Peters's most active month to acquire stocks was the month of May. 2022 was Richard Peters's most active year for disposing of shares, totalling 5 transactions. Richard Peters's most active month to dispose stocks was the month of June. 2017 saw Richard Peters paying a total of $0.00 for 2,000,000 shares, this is the most they've acquired in one year. In 2021 Richard Peters cashed out on 4,520 shares for a total of $50,191.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KINETA, INC./DE (KA) Snapshot price: $0.65
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4
| -2.14% | -1.93K |
$1.86 | -$3,591.66 | 88.1K |
Dec 16
| |||
Form 4
| -10.79% | -10.89K |
$1.69 | -$18,418.26 | 90.03K |
Dec 2
| |||
Form 4
| -4.34% | -4.58K |
$1.85 | -$8,476.27 | 100.92K |
Jul 5
| |||
Form 4
| -8.82% | -10.21K |
$1.19 | -$12,192.09 | 105.5K |
Jun 3
| |||
Form 4
| -8.48% | -10.71K |
$1.85 | -$19,774.53 | 115.71K |
Scheduled
|
Mar 28
| ||
Form 4
| +124.06% | 70K |
—
|
—
| 126.42K |
Dec 1
| |||
Form 4
| -7.42% | -4.52K |
$11.10 | -$50,191.92 | 56.42K |
Jul 2 - Jul 6
| |||
Form 4
|
∞
| 60.94K |
—
|
—
| 60.94K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRIMACK PHARMACEUTICALS INC (MACK) No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +101.55% | 1.04K |
—
|
—
| 2.07K |
Jun 20
| |||
Form 4
| +94.52% | 500 |
—
|
—
| 1.03K |
Aug 23
| |||
Form 4
| +130.04% | 6K |
—
|
—
| 10.61K |
Jul 28
| |||
Form 4
|
∞
| 4.61K |
—
|
—
| 4.61K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||